Ocular Therapeutix GAAP EPS of -$0.35 beats by $0.04, revenue of $13.48M beats by $0.28M (OCUL:NASDAQ)
· seekingalpha.com
Ocular Therapeutix (OCUL) Q2 2026 earnings: GAAP EPS -$0.35 beats estimates; revenue $13.48M tops expectations.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...